Polidocanol injectable foam (Varithena), the only U.S. Food and Drug Administration (FDA)-approved foam for the treatment of incompetent great saphenous veins (GSV), accessory saphenous veins and visible varicosities of the GSV system both above and below the knee.

HIPAA, HIPPA, cyber security concerns are rising over how to better securing patient records.

The healthcare industry is becoming more mobile and efficient than ever before thanks to the adoption of technologies such as electronic health records (EHR) and electronic sharing, storing and accessing of medical data. These advances have all helped to give patients a more dynamic and comprehensive healthcare experience. They have also helped empower patients to take control of their own healthcare history and information.    

OrbusNeich announced first patient enrollment in the Randomized Evaluation of short-term Dual anti platelet therapy in patients with acute coronary syndrome treated with the Combo Dual Therapy StEnt (REDUCE) Study. 

The Healthcare Accreditation Colloquium announced that Texas Children's Hospital has earned the designation of Accredited Pediatric Heart Failure Institute following 12 months of work and an extensive onsite review.

 

August 15, 2014 — The National Institutes of Health (NIH) has launched the NIH 3-D Print Exchange, a public website that enables users to share, download and edit 3-D print files related to health and science. These files can be used, for example, to print custom laboratory equipment and models of bacteria and human anatomy.

August 15, 2014 — Mardil Medical announced earlier this year the first-in-human implants using the VenTouch ventricular reshaping device performed by a surgical team at the Institut Jantung Negara (IJN) National Heart Institute in Kuala Lumpur, Malaysia. This novel, investigational device was implanted in two patients with severe functional mitral valve regurgitation (FMR), which was reduced to only trace amounts after implantation. The patients are part of a multicenter, global clinical study.

August 15, 2014 — Zoll Medical Corp. announced its Japanese subsidiary, Asahi Kasei Zoll Medical (AZM), has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare to enter the Japanese market with its R Series monitor/defibrillator.

August 15, 2014 — Marking the 30th anniversary of the publication of their first joint guidelines for the diagnosis and treatment of heart disease, the American College of Cardiology (ACC) and the American Heart Association (AHA) published an extensive review of the process and methodology for evaluating cardiovascular research and writing practice guidelines for clinicians.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now